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Edited by Horst FeldmannAbstract Seryl-tRNA synthetases (SerRSs) fall into two dis-
tinct evolutionary groups of enzymes, bacterial and methano-
genic. These two types of SerRSs display only minimal
sequence similarity, primarily within the class II conserved mo-
tifs, and possess distinct modes of tRNASer recognition. In order
to determine whether the two types of SerRSs also diﬀer in their
recognition of the serine substrate, we compared the sensitivity of
the representative methanogenic and bacterial-type SerRSs to
serine hydroxamate and two previously unidentiﬁed inhibitors,
serinamide and serine methyl ester. Our kinetic data showed
selective inhibition of the methanogenic SerRS by serinamide,
suggesting a lack of mechanistic uniformity in serine recognition
between the evolutionarily distinct SerRSs.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Aminoacyl-tRNA synthetases (aaRSs) catalyze acylation of
transfer RNAs with their cognate amino acids, and thus pos-
sess a central role in assuring faithful transmission of genetic
information. Essentiality of their function has made aaRSs
attractive targets for drug design, while their structural and
evolutional diversity provides a constructive foundation that
is readily exploited in the identiﬁcation of species-speciﬁc en-
zyme inhibitors.
Evident lack of phylogenetic uniformity is observed among
seryl-tRNA synthetases (SerRSs), which diverge into two
major and disparate types of enzymes. The bacterial-type SerRS
is present in bacteria, eukaryota and a majority of archaea,
whereas methanogenic archaea, with the exception ofMethano-
sarcina mazei and Methanosarcina acetivorans, possess the
methanogenic-type SerRS [1] (Fig. 1). Most conspicuous diﬀer-
ences between the two types of SerRSs include insertions in the
N-terminal domain of methanogenic proteins and a deletion
within the motif 2 loop, which was demonstrated to participateAbbreviations: aaRS, aminoacyl-tRNA synthetase; SerRS, seryl-tRNA
synthetase (EC 6.1.1.11)
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[2]. Such dissimilarity suggests that modes of substrate recogni-
tionmay diﬀer between the two types of SerRSs. In this respect it
is also noteworthy that only a single residue involved in serine
recognition of the bacterial-type SerRSs (Glu279 of T. thermo-
philus, which interacts with both serine hydroxyl and amino
groups) preserves its identity in the methanogenic sequences
(Fig. 1).On the other hand, despite the conservation of the active
site residues within the bacterial-type SerRSs, eukaryotic en-
zymes are characterized by the presence of a C-terminal exten-
sion that aﬀects optimal serine recognition: reportedly,
C-terminal deletion in the yeast SerRS impaired tRNA-facili-
tated serine recognition, as shown by a 3-fold increase of the ser-
ine KM value [3]. Moreover, functional implications of the
structural diﬀerences between methanogenic, bacterial and
eukaryotic SerRSs may be observed in their respective modes
of tRNASer recognition, which display notable disparities [1,4].
In order to assess whether the diﬀerences between the SerRS
enzymes also pertain to serine recognition we analysed the sen-
sitivity of the coexisting bacterial and methanogenic-type Met-
hanosarcina barkeri SerRSs to serine hydroxamate, a known
inhibitor of the Escherichia coli and yeast SerRSs [5–9], and
two previously unidentiﬁed inhibitors, serine methyl ester
and serinamide. Additionally, the E. coli and S. cerevisiae en-
zymes were examined as representative bacterial-type SerRSs
of bacterial and eukaryotic origin, respectively. We show that
distinct types of SerRSs display diﬀerential inhibitory proﬁles,
and propose that such dissimilarity is both consequential and
informative in respect of their evolutionary origin.2. Materials and methods
2.1. Cloning and expression of seryl-tRNA synthetases
Methanogenic and bacterial-type SerRS genes were cloned as de-
scribed [1]. E. coli serSwas ampliﬁed by PCR using Expand High Fidel-
ity polymerase (Roche), and cloned into the pET15b vector (Novagen).
N-terminally His6-taggedM. barkeri andE. coli proteins were produced
according to the published procedure [10]. The yeast SerRS gene SES1
waspreviously cloned into vector pCJ11 for the expression in theSaccha-
romyces cerevisiae strain S2088 [3]. S. cerevisiae SerRS was puriﬁed on a
series of chromatographic columns, as described [11].2.2. Aminoacylation assay
Aminoacylation was performed in 50 mM HEPES–KOH pH 7.2,
50 mM KCl, 15 mM MgCl2, 5 mM dithiothreitol, with 10 mM ATP,
20 lg/lL total tRNA, and [14C] serine at concentrations varying
between 0.2 and 5 timesKM serylationwith theM. barkeri andE. coli en-
zymes was performed at 37 Cwith E. coli unfractioned tRNA, whereasblished by Elsevier B.V. All rights reserved.
Fig. 1. Alignment of motifs 2 and 3 from a number of representative SerRSs. The sequences are from Methanosarcina barkeri-methanogenic-type
SerRS (mMba),Methanococcoides burtonii (Mbu),Methanocaldococcus jannaschii (Mja),Methanococcus maripaludis (Mma),Methanopyrus kandleri
(Mka), Archaeoglobus fulgidus (Afu), Saccharomyces cerevisiae (Sce), Escherichia coli (Eco), Methanosarcina barkeri-bacterial-type SerRS (bMba)
and Thermus thermophilus (Tth). ‘‘s’’ and ‘‘a’’ denote residues in Thermus thermophilus sequence that participate in serine and adenylate recognition,
respectively (Val272 and Arg386 form only main chain interactions). Note that residues involved in adenylate recognition are strictly conserved,
whereas those involved in serine recognition are not.
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SerRS at 30 C.Enzyme concentrationswere experimentally determined
in order to obtain linear velocities. Radioactive aminoacyl-tRNA syn-
thesized after 2–8 min was quantiﬁed as described previously [10]. The
kinetic constants were derived from Hanes–Woolf plots.
2.3. Selection of serine analogues
The following serine analogues (Sigma) were analysed as potential
inhibitors of the methanogenic and bacterial-type M. barkeri enzymes:
serinamide, serine methyl ester, serine hydroxamate, serinol,-methyl
serine, O-methyl serine, phosphoserine, serine ethyl ester and N-acetyl
serine. Aminoacylation was performed at 37 C with 5 lM [14C] serine,
1 mM serine analogue and 125 nM methanogenic SerRS or 30 nM
bacterial SerRS. The level of inhibition was determined as a ratio of
initial velocities of inhibited and uninhibited reactions. Analogues that
showed diﬀerent proﬁle of inhibition by the two M. barkeri enzymes
were kinetically analysed with all representative SerRSs.
2.4. Kinetic analysis of inhibition
To determine KI values for serine inhibitors, at least ﬁve diﬀerent
concentrations were ﬁrst screened in the aminoacylation reaction
under standard conditions with 5 lM [14C] serine. Inhibitor concentra-
tions were then established, at which the initial rate of aminoacylation
was decreased by 20–60% when compared with the uninhibited reac-
tion; these levels were used for KI determinations (three diﬀerent con-
centrations for each inhibitor). In all cases, stock solutions of
inhibitors were maintained at neutral pH. The enzyme concentrations
were 400 nM for the methanogenic, 225 nM for the bacterial M. bark-
eri SerRS, 53 nM for the E. coli SerRS and 203 nM for the yeast en-
zyme. The kinetic constants were derived from Hanes–Woolf and
KMi/VMi versus I plots [12]. Final individual kinetic parameters are
the average of three independent determinations.3. Results
3.1. Divergence of SerRSs
Our phylogenetic analysis of available SerRS sequences
(Fig. 2) conﬁrmed the known division between the methano-genic and bacterial-type sequences [13]. Bacterial-type SerRSs
exhibit lower evolutionary distances, but still preserve a basic
canonical pattern with grouping of archaeal and eukaryotic
proteins and distinction of bacterial sequences. Nonetheless,
horizontal gene transfers are evident within this group: bacte-
rial-type SerRSs in Methanosarcina species and Halobacteria
are almost certainly results of such events, as these enzymes
group with bacterial, rather than archaeal proteins. Accord-
ingly, the original methanogenic-type SerRSs may have been
replaced by the bacterial enzymes in these organisms; in this re-
spect, M. barkeri may represent an intermediate stage in this
process with two types of SerRSs.
3.2. Diﬀerential sensitivity to serine analogues
Since the binding of tRNASer induces conformational
changes [2] that facilitate binding of serine to the active site
of bacterial-type SerRS [11], we chose to measure the steady-
state aminoacylation kinetics of representative SerRS enzymes.
Initially, various serine analogues were used as probes for iden-
tiﬁcation of possible structural and functional diﬀerences be-
tween the two major types of SerRSs represented by the two
M. barkeri SerRSs. Our results show that only serine hydroxa-
mate, serine methyl ester and serinamide inhibited serylation
by the methanogenic SerRS to a considerable level (Fig. 3).
Moreover, these compounds showed a seemingly diﬀerential
eﬀect on the methanogenic and bacterial SerRSs, and were
accordingly examined in a kinetic analysis with representative
SerRSs of methanogenic, bacterial and eukaryotic origin.
Kinetic analysis revealed increased KM values upon inhibi-
tion, thus conﬁrming the competitive nature of serine ana-
logues. The data also showed a marked variation of
serinamide KI values between the representative SerRSs
(Fig. 4): the sensitivity to serinamide is signiﬁcantly more
Fig. 2. Unrooted phylogenetic tree of seryl-tRNA synthetases implied by the neighbor-joining method. Archaeal sequences are shown in bold italics,
bacterial in grey italics, and eukaryotic as plain text. m M. barkeri denotes the methanogenic, and b M. barkeri bacterial-type protein.
Fig. 3. Activity of the methanogenic and bacterial M. barkeri seryl-
tRNA synthetases in the presence of serine analogues. Aminoacylation
was performed with 5 lM serine and 1 mM analogue. % activity is
calculated from initial velocity, relative to the uninhibited reaction.
Fig. 4. Inhibition proﬁles of representative seryl-tRNA synthetases. KI
values are plotted on logarithmic scale.
4346 D. Ahel et al. / FEBS Letters 579 (2005) 4344–4348pronounced in the methanogenic M. barkeri SerRS than in
other, bacterial-type enzymes. The most striking diﬀerences
are observed for the yeast and the bacterial M. barkeri SerRS,
whose KI values diﬀer from the methanogenic M. barkeri
SerRS inhibition constant by several orders of magnitude.Thus, the relative serinamide KI values (Fig. 4) reveal an
approximately 5000-fold diﬀerence between the yeast and
methanogenic M. barkeri SerRSs, and a 300-fold distinction
in the case of the bacterial and methanogenic M. barkeri en-
zymes. On the other hand, the KI values of serine hydroxamate
and serine methyl ester display a lesser degree of variation be-
tween diﬀerent SerRSs (18-fold for serine hydroxamate and 35-
fold for serine methyl ester at the most) (Fig. 4). Our current
studies do not reveal a notable diﬀerence in sensitivity to serine
hydroxamate between by the E. coli and yeast enzymes, as re-
ported previously [8]; the discrepancy is mostly due to the sig-
niﬁcantly higher KI value for the E. coli SerRS, determined
D. Ahel et al. / FEBS Letters 579 (2005) 4344–4348 4347recently in our laboratory (2.1 ± 0.3 mM), in comparison with
the published data (30 lM) [6].
Apparently, the methanogenic SerRS is more susceptible to
inhibition by all three serine analogues than are the bacterial-
type enzymes from M. barkeri, E. coli or yeast (although the
diﬀerence is much less pronounced for serine hydroxamate
and serine methyl ester; Fig. 4). However, with respect to the
eﬃcacy of the inhibition, neither serine hydroxamate nor serine
methyl ester displayed aﬃnities for the target enzymes that are
comparable to the aﬃnities of the natural substrate serine
(Fig. 4): whereas theKM values of all four enzymes are in micro-
molar range (25 lM for the methanogenic M. barkeri SerRS,
34 lM for the bacterial M. barkeri SerRS, 60 lM for the
E. coli SerRS and 62 lM for the yeast SerRS), the KI values
of serine hydroxamate and serine methyl ester fall into the
(sub-)millimolar range. The same applies to serinamide; the
only exception is the methanogenic M. barkeri SerRS, whose
KI value of 3.2 lM signiﬁes that serinamide is apparently pref-
erable to serine (KM = 25 lM) with respect to the binding
aﬃnity.4. Discussion
4.1. Mechanistic implications of inhibition studies
Among the serine analogues used in this study, only serine
hydroxamate, serine methyl ester and serinamide were success-
ful in conferring inhibition. As conﬁrmed by the crystallo-
graphic evidences of the T. thermophilus SerRS, the binding
pocket eﬀectively assures serine speciﬁcity by disallowing over-
sized side chains, and we may speculate that such strategy is
unanimous among the SerRSs, despite their evolutionary
divergence. Presumably, whereas steric clashes preclude bind-
ing of a-methyl serine, O-methyl serine, phosphoserine and
N-acetyl serine, causing their inhibitory incompetence, serinol
is unlikely to induce steric hindrance; the fact that it is ineﬃ-
cient in inhibiting serylation activity suggests that its initial
binding to the SerRS pocket is disfavoured due to the reduced
capacity of hydrogen bond formation, i.e., the absence of the
carbonyl oxygen.
Not surprisingly, diﬀerences in the inhibitory proﬁle of the
tested SerRSs are most striking between the methanogenic-
type and any of the bacterial-type enzymes (Fig. 4). In partic-
ular, binding aﬃnities of the bacterial and methanogenic M.
barkeri SerRSs for serinamide diﬀer by more than two orders
of magnitude. Although the yeast enzyme displays a more dis-
cernible distinction compared to the methanogenic M. barkeri
SerRS, the diﬀerence between the two M. barkeri enzymes is
more intriguing because these SerRSs coexist in the same cel-
lular environment. Such diﬀerential binding of serinamide
could likely be correlated to the fundamentally diﬀerent modes
of serine recognition in the methanogenic and the bacterial-
type SerRSs. This assumption is supported by the minimal
conservation of the residues crucial for serine recognition in
bacterial-type enzymes among their methanogenic analogues
(Fig. 1).
Among the bacterial-type enzymes, SerRSs from M. barkeri
and E. coli show apparent similarity in their inhibition proﬁles,
and their KI values do not diﬀer substantially (Fig. 4). How-
ever, in the case of the yeast enzyme, the pattern of inhibition
is slightly changed: while serinamide seems to be more potent
than hydroxamate against the E. coli andM. barkeri bacterial-type SerRSs, the situation is reversed for the yeast enzyme.
Such grouping is well supported by the phylogenetic data
(Fig. 2): evidences of horizontal gene transfers in Methanosar-
cina species clearly account for the similar inhibition pattern of
the M. barkeri and E. coli SerRSs, whereas the noted distinc-
tion in the proﬁle between the bacterial versus eukaryotic en-
zymes appears to reﬂect the apparent evolutionary distance.
Alternatively, this diﬀerence could be attributed to the eukary-
ote-speciﬁc C-terminal extension, as it was proposed to be
important for serine recognition [3].
Analogously to our results, indolmycin, pseudomonic acid,
thialysine and borrelidin, naturally existing inhibitors of try-
ptophanyl-, isoleucyl-, lysyl- and threonyl-tRNA synthetases,
respectively, were shown to preferentially inhibit only certain
subtypes of their corresponding aminoacyl-tRNA synthetase
targets [14–17]. In this context, evaluation of sensitivity to sub-
strate analogues appears to be a valuable strategy for identify-
ing diﬀerences between the evolutionary divergent synthetases,
as well as a means of probing more subtle diﬀerences between
related enzymes. Furthermore, it may also provide a more gen-
eral outlook on the biological signiﬁcance of duplicated aaRS
genes, as discussed below.4.2. Duplicated aaRSs
Available data do not suggest functional complementarity of
the two M. barkeri enzymes, and it remains unclear why they
coexist in this organism. As suggested, the duplicity of SerRSs
in M. barkeri may represent an evolutionary interphase that
precedes the loss of the redundant serS gene. On the other
hand, additional functions pertaining to either of these en-
zymes cannot be excluded; in this respect it seems noteworthy
that the bacterial SerRS is less stringent in recognition of
tRNASer, as indicated by our study [1]. Moreover, the two serS
genes may be regulated diﬀerently, and expression proﬁles of
these SerRSs may be revealing in terms of their functionality.
Furthermore, diﬀerential sensitivity of the two enzymes to
the inhibitory eﬀect of the serine analogues possibly indicates
that the two dissimilar SerRS forms may provide resistance
to a wider spectrum of potential natural or synthetic inhibi-
tors, and hence be of great advantage to their host. It has also
been suggested that the divergence of the LysRS forms pre-
vents inﬁltration of non-canonical amino acids into the genetic
code, and thus contributes to quality control of protein synthe-
sis [18]. Considering that the duality of aaRS systems in M.
barkeri includes both unrelated SerRS and LysRS enzymes,
we may speculate that such diversity is maintained as a result
of selective pressure. Interestingly, M. barkeri thrives in a vari-
ety of environments, such as anoxic freshwater mud or rumen
of cattle [19]. As the intestinal system of grazing animals in-
volves dramatic changes of concentrations of amino acids,
their analogues and other potential inhibitors, it likely creates
the turbulent and potentially detrimental surrounding to which
essential enzymes, such as aaRSs, are challenged to adjust. In
this respect, alternative SerRS and LysRS systems may be pre-
sumed to facilitate the adaptation of M. barkeri to the distinct
ecological niches.
Lastly, existence in natural environments involves competi-
tion between co-inhabitants that have developed a diversity
of targeted inhibition-resistance strategies. In view of that, it
was reported that Pseudomonas ﬂuorescens produces a speciﬁc
inhibitor of the bacterial-type IleRS (pseudomonic acid) to kill
4348 D. Ahel et al. / FEBS Letters 579 (2005) 4344–4348competing bacteria, whereas it avoids suicide by maintaining a
second copy of IleRS that is of eukaryotic origin and resistant
to pseudomonic acid [15]. Whether M. barkeri uses an analo-
gous strategy with the SerRS system remains an attractive
speculation; size and diversity of its genome certainly leave this
option feasible.
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